Soleil Boughton serves as Executive at Hims & Hers Health, Inc., where they oversee executive responsibilities. Since joining the company, Soleil Boughton has executed 105 insider transactions totaling $9.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 16, 2021 involved exercising options for 10,086 shares valued at $0.
Soleil Boughton currently holds 171,829 shares of Hims & Hers Health, Inc. (HIMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Soleil Boughton has been a net seller of HIMS stock. They have purchased $0 and sold $9.8M worth of shares.
Soleil Boughton's most recent insider trade was on Jun 16, 2021, when they sold 10,086 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $10.56 |
| Discretionary |
| May 24, 2021 | HIMS | $30.9K | Payment | 2,928 | $10.56 | Discretionary |
| May 20, 2021 | HIMS | $0 | Option Exercise | 8,473 | $N/A | Discretionary |
| Jan 20, 2021 | HIMS | $0 | Award | 367,735 | $N/A | Discretionary |